AMA says time running down on master agreement drafting deadlineEDMONTON | The president of the Alberta Medical Association is beginning to worry that a promised physician master agreement won’t be hammered out with Alberta Health Services or Alberta Health and Wellness by an end of June deadline. Safinamide disappoints in preventing dyskinesia in Parkinson's patientsThe new drug safinamide might have some impact in preventing the involuntary movements characteristic of Parkinson's disease. However, it did not perform any better than placebo over a two-year period. Allergies shown to vary by birth order First-born more likely to be food-allergic than younger siblings Oral immunotherapy bests sublingual for milk allergy But oral therapy associated with more frequent adverse events Regional riddle emerges from epilepsy drug study New treatment is effective in Canada and U.S., but not in rest of North America; epilepsy classification may have been a factor Alberta conference celebrates centennial Official celebration to mark a century of practice in the province kicks off at Alberta Pharmacy Centennial Conference. Sublingual therapy for peanut allergy needs more study Study shows it's safe and can desensitize, but response range is wide Canadian MS clinics see results with natalizumab Real-world outcomes with investigational drug still favourable Video: The pharmacist your pharmacist could be... UBC pharmacy students create spoof of wildly-popular Old Spice Byetta: second GLP-1 agonist for diabetes Indicated for use in combination with metformin and/or a sulfonylurea to improve glycemic control in adults with type 2 diabetes. First Previous 2091 2092 2093 2094 2095 Next Last
